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On the basis of the experimentally determined kinetic
properties of the trypanosomal enzymes, the question is
addressed of which step limits the glycolytic flux in
bloodstream form Trypanosoma brucei. There appeared
to be no single answer; in the physiological range, con-
trol shifted between the glucose transporter on the one
hand and aldolase (ALD), glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), phosphoglycerate kinase
(PGK), and glycerol-3-phosphate dehydrogenase (GDH)
on the other hand. The other kinases, which are often
thought to control glycolysis, exerted little control; so
did the utilization of ATP.
We identified potential targets for anti-trypanosomal
drugs by calculating which steps need the least inhibi-
tion to achieve a certain inhibition of the glycolytic flux
in these parasites. The glucose transporter appeared to
be the most promising target, followed by ALD, GDH,
GAPDH, and PGK. By contrast, in erythrocytes more
than 95% deficiencies of PGK, GAPDH, or ALD did not
cause any clinical symptoms (Schuster, R. and Holzhu¨t-
ter, H.-G. (1995) Eur. J. Biochem. 229, 403–418). There-
fore, the selectivity of drugs inhibiting these enzymes
may be much higher than expected from their molecular
effects alone. Quite unexpectedly, trypanosomes seem to
possess a substantial overcapacity of hexokinase, phos-
phofructokinase, and pyruvate kinase, making these “ir-
reversible” enzymes mediocre drug targets.
Trypanosoma brucei is a unicellular, eukaryotic parasite. It
causes the African sleeping sickness in humans and a related
disease, nagana, in livestock. When this organism lives in the
mammalian bloodstream, it depends completely on glycolysis
for its supply of ATP. It possesses neither a functional Krebs
cycle nor oxidative phosphorylation, nor does it store any car-
bohydrate. Glycolysis in trypanosomes and in other members of
the Kinetoplastida family differs substantially from the corre-
sponding pathway in other organisms (for reviews see Refs.
1–4). First, the conversion of glucose to 3-phosphoglycerate
(3-PGA)1 takes place in specialized organelles, related to per-
oxisomes. Since 90% of the protein content of these organelles
consists of glycolytic enzymes, they have been called glyco-
somes (5). The glycosomal membrane is hardly permeable to
metabolites (6). Second, under aerobic conditions, the NADH
produced in glycolysis is reoxidized by molecular oxygen via a
mitochondrial glycerol 3-phosphate:DHAP (Gly-3-P:DHAP)
shuttle (Fig. 1). Since there is neither a cytosolic glycerol ki-
nase (GK) nor any significant activity of glycerol 3-phosphatase
(5, 7), all Gly-3-P is shuttled back via DHAP to the mitochon-
dria and converted to pyruvate, leading to the production of two
molecules of pyruvate per molecule of glucose consumed. Under
anaerobic conditions, equimolar amounts of pyruvate and glyc-
erol are produced due to requirements of glycosomal redox and
ATP balance (1, 5, 7–10). This decreases the ATP production to
one molecule of ATP per glucose. Third, the glycosomal en-
zymes are hardly regulated by any of the compounds that
strongly affect the corresponding enzymes in other organisms.
Most notably, in trypanosomes, fructose 2,6-bisphosphate acti-
vates the cytosolic enzyme PYK (11–13) rather than the gly-
cosomal PFK (14, 15). The physiological function of this ac-
tivation is elusive, since the fructose 2,6-bisphosphate concen-
tration in the bloodstream form substantially exceeds its ac-
tivation constant for PYK (12, 16).
It has been suggested that the transport of glucose into the
cells is the rate-limiting step of glycolysis in bloodstream form
trypanosomes (17). Yet, our present day knowledge of control of
metabolism led us to re-evaluate the evidence for this state-
ment (4). Since the development of metabolic control analysis
(18, 19) (for reviews, see Refs. 20 and 21), it has been known
that in general there is no single rate-limiting step in a meta-
bolic pathway, but control can be shared among several steps.
The quantitative measure of the strength of the control of the
steady-state flux J through a pathway by an enzyme i in this
pathway is given by its flux control coefficient, Ci
J. This coeffi-
cient is defined as the percentage increase of the flux caused by
a 1% activation of enzyme i (for a more precise definition see
Refs. 22 and 23). Flux control coefficients can have any value
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between 0 (not limiting) and 1 (completely rate-limiting) (e.g.
Refs. 24–28), but the sum of the flux control coefficients of all
enzymes in the pathway should be 1 (18).
To measure a flux control coefficient, it is necessary to mod-
ulate the activity of the enzyme of interest with small steps
around the normal wild type level. For the trypanosome glu-
cose transporter, this has not been done. Consequently, the
evidence presented for the glucose transporter being rate-lim-
iting is only indirect and qualitative. In the first place, glucose,
fructose, and mannose were metabolized at different rates (17).
However, the comparison of different substrates alone did not
correspond to the small modulation required for metabolic con-
trol analysis. In addition, the modulation of the transport ac-
tivity was not quantified, nor did this experiment exclude con-
trol by phosphorylation. Also the low intracellular glucose
concentration (0.4 mM) has been taken as evidence that glucose
transport was rate-limiting (29). However, a theoretical anal-
ysis, based on the kinetics of the glucose transporter and of HK,
showed that an intracellular glucose concentration of 0.4 mM
may be consistent with any flux control coefficient between 0
and 50%, but not 100% (4). This suggests that, if at all impor-
tant, glucose transport is not the only step controlling trypano-
some glycolysis.
Because bloodstream form trypanosomes depend completely
on glycolysis for their supply of ATP and because the organi-
zation of glycolysis in the parasite is very different from that in
the host cells, this pathway has been selected as a target for
drugs against the African sleeping sickness (30). The selectivity
of drugs might be enhanced by choosing a target enzyme that
has a high control in the parasite and a low control in the host.
Despite the great interest, it is not yet known completely for
any organism how the control of the glycolytic flux is distrib-
uted. In yeast, for example, many genes encoding glycolytic
enzymes (HK, phosphoglucose isomerase, PGK, PYK, pyruvate
decarboxylase, alcohol dehydrogenase) have been overex-
pressed manifold, but in none of the mutants did the glycolytic
flux differ substantially from the wild type flux (31, 32). This
may be due to several reasons. First, glycolysis in yeast (and
many other organisms) is part of a much wider metabolic
network. Consequently, the glycolytic flux may be controlled by
steps outside glycolysis, such as the utilization of ATP, the
respiratory branch, the synthesis of storage carbohydrates,
and/or the glucose transporter proteins (33). Second, the effects
of overexpression are necessarily investigated at time scales at
which the cells may adjust the expression of other genes. For
example, the PFK-overproducing cells contained decreased lev-
els of 6-phosphofructo-2-kinase. Thus, they compensated for
the increased amount of PFK by decreasing the concentration
of its activator fructose 2,6-bisphosphate (32). Finally, when
the activity of an enzyme is increased, it often (but not always)
loses control (34). By using overexpression mutants, one there-
fore runs the risk of underestimating the control coefficients.
Several studies dealt with the control of glucose utilization in
mammalian cells. Measurements indicated that the rate of
glycogen synthesis was controlled by glucose transport and
hexokinase (35). The control of mammalian glycolysis has been
measured by the so-called matrix inversion method (36). In the
absence of insulin, most control was shared by glucose trans-
port and hexokinase. This method, however, requires that all
relevant enzymes be included, but important steps such as
PFK and GAPDH were missing.
The above mentioned problems with the determination of
control coefficients should not apply, or should apply to a lesser
extent, to bloodstream form T. brucei. First, except for the
utilization of ATP, there are no branches with a substantial
flux under aerobic conditions. Second, the kinetics of glycolytic
enzymes from T. brucei have been investigated thoroughly in a
limited number of laboratories under standard conditions. This
has enabled us to develop a detailed kinetic model of trypano-
some glycolysis containing most glycolytic enzymes. The model
calculations of the flux and the metabolite concentrations cor-
responded unexpectedly well with experimental information
(37). We here use the kinetic data to calculate what controls
trypanosome glycolysis under physiological conditions. It will
be shown that there is a distribution of control of trypanosome
glycolysis, which depends strongly on glucose supply.
MATERIALS AND METHODS
Cultivation of Trypanosomes
All experiments were performed with the bloodstream form of T.
brucei stock 427. Male, 300-g Wistar rats were infected with T. brucei,
and the parasites were isolated from the blood by DEAE-cellulose
chromatography (DE52, Whatman) (38). The cells were washed by
centrifugation; resuspended in a 90 mM Tris/HCl buffer containing 2.5
mM KCl, 77.5 mM NaCl, 5 mM MgCl2, 2 mM Na2HPO4, and 50 mM
glucose at pH 7.5 (modified from Ref. 39); and stored on ice. In this
buffer, the cells maintained a constant motility and oxygen consump-
tion capacity for at least 7 h after isolation.
Flux and Metabolite Measurements
An aliquot of cells was washed three times by centrifugation at 4 °C
and resuspended in the assay buffer at 37 °C. The measurements were
performed in a 90 mM Tris/HCl buffer (pH 7.5), containing 3.1 mM KCl,
96.9 mM NaCl, 5 mM MgCl2, 2 mM Na2HPO4, and the indicated concen-
tration of glucose. The protein concentration was measured in each
aliquot of cells, according to Lowry (40) with bovine serum albumin as
a standard. Since the buffer weakly disturbed the assay, the same
amount of buffer as present in the samples was added to the bovine
serum albumin standards.
The rate of oxygen consumption was monitored in a closed and
thermostated vessel with a Clark electrode. For determination of the
concentrations of other metabolites, the cells were kept in an open,
thermostated vessel and aerated with water-saturated pressurized air.
To check that the cell suspensions remained aerobic, the oxygen con-
centration was monitored with a Clark electrode throughout the exper-
iment. Samples were taken by injecting 75 ml of the cell suspension into
37.5 ml of 15% perchloric acid. Samples were vortexed, centrifuged (5
min, Eppendorf table centrifuge, full speed), neutralized by mixing 80
ml of supernatant with 45 ml of 1 M K2CO3, and centrifuged again. The
pH of the supernatants was checked with pH paper (pH was between 7
and 8). Supernatants were stored at 220 °C and analyzed further
within 1 week. Glucose, pyruvate, and glycerol were measured by
NADH-linked analysis (41) in an automatic analyzer (COBAS FARA,
Roche Molecular Biochemicals).
Chemicals
Phloretin was from Sigma. A phloretin stock was made up in 70%
ethanol. The ethanol concentration in cell suspensions was always kept
below 1%.
Modeling
The kinetic model of trypanosome glycolysis that was used in this
study has been described and validated previously, its predictions being
compared with experimental results (37). It contained enzyme kinetics,
measured with purified trypanosome enzymes, for most reactions de-
picted in Fig. 1. The reactions catalyzed by phosphoglucose isomerase,
triosephosphate isomerase (TIM), phosphoglycerate mutase, enolase,
and adenylate kinase were taken to be at equilibrium. The rationale
was that their measured ratios of substrate and product concentrations
were close to equilibrium (phosphoglycerate mutase and enolase) (42),
that they catalyze a dead-end branch (adenylate kinase), or that they
were close to equilibrium in initial model calculations with explicit
kinetics for these reactions (phosphoglucose isomerase and TIM). The
glycosomal membrane was assumed to be impermeable to metabolites
(6), except to those that need to be transported to allow glycolysis to
proceed. Because of a lack of kinetic information, the latter transport
steps were assumed to be at equilibrium. The transport of glucose
across the cytoplasmic and subsequently the glycosomal membranes
was lumped into one kinetic equation, because no distinction could be
made so far (29, 43). This is equivalent to assuming the glycosomal
glucose transporter to be at equilibrium. The glycosomal concentration
of inorganic phosphate was assumed to be saturating. This assumption
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has been validated partially. At the normal blood concentration of
inorganic phosphate (0.4–0.5 mM (44)), the measured rate of oxygen
consumption by intact trypanosomes, i.e. the glycolytic flux, was fully
saturated with phosphate (result not shown).
The concentrations of both the adenine nucleotides (ATP, ADP, AMP)
and the nicotinamide adenine nucleotides (NAD, NADH) were treated
as free (although interdependent) variables, rather than fixed param-
eters of the system. Due to the compartmentalization of the pathway,
the model contained distinct pools of cytosolic and glycosomal adenine
nucleotides. In principle, the model allowed both dynamic and steady-
state calculations, but the present study is limited to steady states only.
Below, only the changes that were made to the model described in Ref.
37 are described.
Kinetics—The kinetics of GDH have been determined more accurate-
ly2: Km, DHAP 5 0.1 mM; Km, Gly-3-P 5 2 mM; Km, NADH 5 0.01 mM;
Km, NAD1 5 0.4 mM; and the ratio of the reverse and forward Vmax
(V2/V1) 5 0.28. The specific activity of the purified enzyme in the
forward direction was 213 mmol min21 (mg of enzyme)21. The amount of
GDH in the cell is 0.25% of the total cell protein (45). Expressed per
total cell protein, V1 is then 533 nmol min21 mg of protein21.
Bakker et al. (37) took the hexose kinases to be insensitive to their
products. Originally only an indirect and weak effect of glucose 6-phos-
phate (Glc-6-P) on HK and of fructose 1,6-bisphosphate (Fru-1,6-BP) on
PFK was included in the model via the conservation relation of bound
phosphates. Under some conditions, this might cause the set of equa-
tions defining the steady state to be underdetermined. This would be
the case, for instance, if ALD were saturated with Fru-1,6-BP. Then
none of the enzymes would sense the concentration of Fru-1,6-BP, and
consequently the latter could assume any value, only restricted by the
conserved sum. It has been reported that Fru-1,6-BP does inhibit PFK,
by acting both on the Vmax and the Km for Fru-6-P (14). In the present
study the following rate equation was used,
nPFK 5 V1 z S Ki1@Fru-1,6-BP# 1 Ki1D z
1
@Fru-6-P#
Km,Fru-6-P
1 1
@Fru-6-P#
Km,Fru-6-P
1
@Fru-1,6-BP#
Ki2
2 z 1
@ATP#
Km,ATP
1 1
@ATP#
Km,ATP
2 (Eq. 1)
in which Ki1 5 15.8 mM and Ki2 5 10.7 mM (14). All other parameters
held the same values as described previously (37). HK was reported to
be insensitive to Glc-6-P (46). Due to salt effects and a high affinity of
the enzyme for glucose (Km 5 0.1 mM), a competitive inhibition by
Glc-6-P with a Km above 10 mM would not be measurable.
3 Under some
conditions, such a weak inhibition was relevant to prevent unrestrained
accumulation of Glc-6-P in the model, and therefore the rate equation
was modified to the following equation.
nHK 5 V1 z 1
@Glc#
Km,Glc
1 1
@Glc#
Km,Glc
1
@Glc-6-P#
Km,Glc-6-P
2 z 1
@ATP#
Km,ATP
1 1
@ATP#
Km,ATP
1
@ADP#
Km,ADP
2 (Eq. 2)
Km,Glc-6-P was taken to be 12 mM, which does not contradict the meas-
urements. The other parameters were not changed (37).
The rate of PYK was assumed to be independent of the concentra-
tions of its products, ADP and pyruvate, unless otherwise mentioned. If
the rate depended on the ATP concentration, the following rate equa-
tion was used.
nPYK 5 V1 z 1 S
@P-enolpyruvate#
Km,P-enolpyruvate
Dn
1 1 S@P-enolpyruvate#Km,P-enolpyruvate D
n2 z 1
@ADP#c
Km,ADP
1 1
@ADP#c
Km,ADP
1
@ATP#c
Km,ATP
2
(Eq. 3)
Km,ATP was taken to be 0.1 mM (equal to Km,ADP (47)), and the other
parameter values were not changed (37).
Non-competitive inhibition of glucose transport was simulated by
multiplying the rate equation for glucose transport by a factor Ki/(Ki 1
[I]), in which [I] represents the inhibitor concentration and Ki is the
inhibition constant. Competitive inhibition of glucose transport was
simulated by multiplying the Km values for both extracellular and
intracellular glucose by a factor 1 1 [I]/Ki.
The Transport of Gly-3-P and DHAP—Under anaerobic conditions,
bloodstream form T. brucei maintains its glycosomal redox and ATP
balance by producing equimolar amounts of pyruvate and glycerol (Fig.
1). The DG09 of GK does not favor the production of glycerol. An inhi-
bition of glycolysis by glycerol has indeed been measured under anaer-
obic conditions (48). In the original kinetic model (37), the concentration
of glycerol required to inhibit the flux was much lower than had been
found experimentally. The model assumed the transport of Gly-3-P and
DHAP across the glycosomal membrane to be independent of each other
and at equilibrium. Consequently, any increase of the glycosomal con-
centration of Gly-3-P was accompanied by an identical increase of the
cytosolic concentration of Gly-3-P. Both the cytosolic and the glycosomal
concentration of Gly-3-P participated in a conserved sum of organic
phosphate groups that are not exchanged with inorganic phosphate as
follows,
@Gly-3-P#gVg 1 @Gly-3-P#cVc 1 @DHAP#gVg 1 @DHAP#cVc 1
@Glc-6-P#gVg 1 @Fru-6-P#gVg 1 2@Fru-1,6-BP#gVg 1 @GA-3-P#gVg 1
@1,3-BPGA#gVg 1 2@ATP#gVg 1 @ADP#gVg 5 C4 z Vg (Eq. 4)
in which Vg is the glycosomal volume and Vc is the cytosolic volume.
Since the cytosolic volume was more than 20 times the glycosomal
volume, any increase of the cytosolic Gly-3-P concentration led to an
enormous drain of the glycosomal metabolites. This effect enhanced the
inhibition of the anaerobic glycolytic flux by glycerol.
2 S. Marche´, F. R. Opperdoes, and P. A. M. Michels, unpublished
results.
3 J. van Roy and F. R. Opperdoes, unpublished results.
FIG. 1. The stoichiometric scheme of the model of glycolysis in
bloodstream form T. brucei. The reactions 3, 6, 9, 13, 16, 18, and 19
were treated as equilibrium reactions. 1, transport of glucose across the
plasma membrane and the glycosomal membrane; 2, HK; 3, phospho-
glucose isomerase; 4, PFK; 5, ALD; 6, TIM; 7, GAPDH; 8, PGK; 9,
transport of 3-PGA across the glycosomal membrane, phosphoglycerate
mutase, and enolase; 10, PYK; 11, pyruvate transport across the plasma
membrane; 12, GDH; 13, transport of Gly-3-P and DHAP across the
glycosomal membrane; 14, glycerol-3-phosphate oxidase; 15, GK; 16,
transport of glycerol across the glycosomal membrane and the plasma
membrane; 17, ATP utilization; 18, glycosomal adenylate kinase; 19,
cytosolic adenylate kinase. PEP, P-enolpyruvate.
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If the transport of Gly-3-P and DHAP would occur via an antiport
mechanism, as proposed by Opperdoes and Borst (5), the conserved sum
of bound phosphates would split in distinct glycosomal and cytosolic
conserved sums.
@Gly-3-P#g 1 @DHAP#g 1 @Glc-6-P#g 1 @Fru-6-P#g 1 2@Fru-1,6-BP#g
1 @GA-3-P#g 1 @1,3-BPGA#g 1 2@ATP#g 1 @ADP#g 5 C4,antiporter (Eq. 5)
and
[Gly-3P]c 1 @DHAP]c 5 C5,antiporter (Eq. 6)
Consequently, an increase of the glycosomal Gly-3-P concentration
would not be automatically coupled to an equal increase of the cytosolic
Gly-3-P concentration. Therefore, it was expected that the inhibition of
anaerobic glycolysis by glycerol would be much weaker. This hypothesis
was tested by implementing a Gly-3-P:DHAP antiporter in the model.
It was assumed that the antiporter was in equilibrium. Also, TIM
was taken to be in equilibrium, as previously. Therefore, the triosephos-
phates were considered to behave as a single metabolite pool.
@triose-P# ;
@DHAP#cVc 1 @DHAP#gVg 1 @GA-3-P#gVg
Vtot
(Eq. 7)
The time derivative of [triose-P] remained exactly the same as in the
model with the two independent transporters (37). The implementation
of the antiporter entailed the solving of a set of five equations with five
unknowns, i.e. Equations 5–7 and the equilibrium constraints for TIM
and the exchanger itself.
@GA-3-P#g
@DHAP#g
5 Keq,TIM (Eq. 8)
@Gly-3-P#c@DHAP#g
@Gly-3-P#g@DHAP#c
5 Keq,antiporter 5 1 (Eq. 9)
It follows that the cytosolic DHAP concentration is as follows,
@DHAP#c 5
2b 1 Îb2 2 4ac
2a
(Eq. 10)
in which
a 5 Keq,TIM z
Vc
Vg
(Eq. 11)
b 5 Q z ~1 1 Keq,TIM! 1
Vc
Vg
z C5,antiporter 2 @triose-P# z S1 1 VcVgD z Keq,TIM
(Eq. 12)
c 5 2@triose-P# z S1 1 VcVgD z C5,antiporter (Eq. 13)
and
Q 5 @DHAP#g 1 @GA-3-P#g 1 @Gly-3-P#g 5 C4,antiporter 2 @Glc-6-P#g
2 @Fru-6-P#g 2 2@Fru-1,6-BP#g 2 @1,3-PGA#g 2 2@ATP#g 2 @ADP#g
(Eq. 14)
When [DHAP]c was known, [DHAP]g followed from equations 5, 6, 8,
and 9.
@DHAP#g 5
Q z @DHAP#c
C5,antiporter 1 Keq,TIM z @DHAP#c
(Eq. 15)
Subsequently, [Gly-3-P]c, [GA-3-P]g, and [Gly-3-P]g were calculated
from Equations 6, 8, and 9, respectively. All other equations in the
model were as specified in Ref. 37. The values of C4,antiporter and the sum
of the glycosomal adenine nucleotides (C1) have not been determined
experimentally. They were chosen as follows: C1 5 6 mM, and C4,antiporter
5 45 mM. C5,antiporter (5 mM) was based on measurements of average
concentrations of Gly-3-P and DHAP in the cell (42). To allow compar-
ison of the model with and without the antiport mechanism, the total
amount of metabolites contained in C4 on the one hand and C4,antiporter
and C5,antiporter on the other hand was kept the same, as follows.
C4 5 C4,antiporter 1 ~Vc/Vg! z C5,antiporter 5 156.5 mM (Eq. 16)
Indeed, the coupling of the transport of Gly-3-P and DHAP transport
made the anaerobic flux less sensitive to glycerol (Fig. 2). The K0.5 of
glycerol increased 7.5-fold from 10 mM (independent transport) to 75 mM
(antiporter). Nevertheless, the calculated K0.5 was still lower than the
measured K0.5 (800 mM) (48). Table I shows that the implementation of
the antiporter did not cause a substantial deviation of the model from
the experiments with regard to the flux and the metabolite concentra-
tions as far as they could be measured in cell extracts (42). Only the
modeled concentration of DHAP deviated more than 3-fold from the
experiments due to the antiporter, while it was correctly predicted if the
transport was uncoupled. The results that will be shown have been
obtained with a Gly-3-P:DHAP antiporter. It was confirmed that these
results were virtually independent of the mechanism of transport.
Quantifying Control—The control of an enzyme i on a steady-state
flux J was defined by its flux control coefficient,
Ci
J 5
~dlnJ/dp!
~­lnn/­p!
z 100% 5
n
J
z
~dJ/dp!
~­n/­p!
z 100% (Eq. 17)
in which n is the rate of enzyme i, p is a parameter that only affects
enzyme i, and (­n/­p) is the effect of the parameter change on n if the
enzyme were isolated from the rest of the metabolic pathway, i.e. at
constant concentrations of all metabolites. The flux control coefficient of
an enzyme or transporter was calculated numerically by increasing its
forward (V1) and reverse (V2) maximal rate in proportion by 0.01% and
calculating the steady-state flux J both prior to and after this change.
Ci
J was evaluated as follows.
Ci
J 5
DJ
DV1
z
V1
J
z 100% (Eq. 18)
It has always been verified that the results obeyed the summation
theorem,
OCiJ 5 100% (Eq. 19)
in which the summation is over all enzymes i in the pathway.
The sensitivity of an enzyme to a metabolite concentration was
evaluated in terms of its elasticity coefficient, defined by the equation,
«Xj
i 5
Xj
ni
z
­ni
­Xj
(Eq. 20)
in which Xj is the concentration of metabolite j. Partial derivatives were
taken at constant concentrations of the other metabolites at their
steady-state values. Numerically, elasticity coefficients were deter-
mined by calculating ni and Xj in the steady state, increasing Xj by
0.01%, and calculating the change of ni.
Control coefficients and elasticity coefficients are related by connec-
tivity theorems. The connectivity theorem for intracellular glucose is,
for example, the following.
Cglucose transport
J z «Glci
glucose transport 1 CHK
J z «Glci
HK 5 0 (Eq. 21)
FIG. 2. The inhibition of the glycolytic flux by glycerol under
anaerobic conditions depends on the stoichiometry of the trans-
port of Gly-3-P and DHAP. The solid line represents the inhibition
curve that was calculated, if it was assumed that these metabolites
were transported independently across the glycosomal membrane. The
dashed line is the corresponding curve if their transport was coupled by
an antiporter. Details of the model can be found under “Materials and
Methods.”
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This means that the process that is the more sensitive to intracellular
glucose has the lower control. This can be understood intuitively, be-
cause the more sensitive process tends to adapt to a change elsewhere
in the system.
If specific conditions are fulfilled (49), a group of enzymes may be
treated as a single module. Under “The Distribution of Control between
the Supply and Demand for ATP” below, this principle was applied. The
glycolytic pathway was simplified to two modules: one producing cyto-
solic ATP (supply) and one consuming it (demand) (20, 50, 51). For this
system, the following modular connectivity theorem holds,
Csupply
J z *«@ATP#c/@ADP#c
supply 1 Cdemand
J z *«@ATP#c/@ADP#c
demand 5 0 (Eq. 22)
in which the asterisk emphasizes that these elasticities apply to the
whole module rather than to a single reaction. The summation theorem
for the flux control coefficients remains as follows.
Csupply
J 1 Cdemand
J 5 100% (Eq. 23)
Together, Equations 22 and 23 yield the following.
Cdemand
J 5
100%
1 2
*«@ATP#c/@ADP#c
demand
*«@ATP#c/@ADP#c
supply
(Eq. 24)
Usually, *e[ATP]c/[ADP]c
supply is negative (product inhibition), and
*e[ATP]c/[ADP]c
demand is positive, so that Cdemand
J is between 0 and 100%. To
calculate the control of PYK on the flux through the supply module
(CPYK
J supply), the cytosolic [ATP]/[ADP] ratio was fixed.
Substrate and Product Concentrations—The extracellular concentra-
tions of glucose, pyruvate, and glycerol were kept constant at 5, 0, and
0 mM, respectively, unless mentioned otherwise.
Software—Conserved sums were analyzed with the program SCAMP
(52). The simulations were performed with MLAB (Civilized Software,
Bethesda, MD).
RESULTS
The Control of the Glycolytic Flux under Physiological Con-
ditions—The first question we addressed was which reactions
or transport steps control the glycolytic flux of trypanosomes in
the mammalian bloodstream. Although the mammalian blood-
stream is a very constant environment in many respects, the
cells may encounter extracellular glucose concentrations vary-
ing between 4 and 8 mM (53, 54). The oxygen concentration is
saturating throughout the vascular system (4). Under aerobic
conditions, only a very small rate of glycerol production was
measured (Table II); therefore, the branch to glycerol was ne-
glected in all aerobic simulations reported here (see also Ref.
37). It was calculated to which extent glucose transport limits
glycolysis under these conditions. Whereas glucose transport
controlled the flux at low extracellular glucose concentrations,
control gradually eluded the transporter at the higher glucose
concentrations, to be taken over by ALD, GAPDH, PGK, and
GDH together (Fig. 3). In accordance with the concepts of
metabolic control analysis, the control was condition-depend-
ent and was shared by several steps at high glucose concentra-
tions. Furthermore, there was no relationship whatsoever be-
tween the extent to which any of the enzymes controlled the
glycolytic flux and its distance from equilibrium (Table III). At
5 mM glucose, the glucose transporter controlled the flux for
more than 90%, but the irreversible enzymes HK, PFK, and
PYK were much further displaced from equilibrium than the
transporter.
The Control by Glucose Transport Is Highly Variable—The
above calculations depend on many kinetic parameters, all of
which have been measured with finite accuracy and some of
which may be subject to biological variation or regulation.
Therefore, the sensitivity of the results to inaccuracies in the
parameter values has been investigated by varying the Vmax
values of all enzymes around their default values at 5 mM
glucose. It turned out that most flux control coefficients de-
pended weakly on the enzyme activities around their measured
values. A most surprising exception was the flux control by the
glucose transporter, which depended strongly on the activities
of various processes. Under aerobic conditions, a relatively
small increase of the activity of the transporter above the
measured value already caused its flux control coefficient to
drop to 0 (Fig. 4). Also, reduction of the Vmax of ALD, GAPDH,
or PGK shifted the control from the transporter to other
TABLE I
The measured and calculated glycolytic flux and metabolite concentrations
The steady-state glycolytic flux and metabolite concentrations, as they were calculated with independent transport of Gly-3-P and DHAP or with
an antiporter, are compared with experimental values (42). The ratios of aerobic to anaerobic concentrations were taken to avoid inaccuracy due
to the conversion of amounts measured in nmol/mg wet weight to intracellular concentrations in mM. Since the measured concentrations represent
a weighted average of glycosomal and cytosolic concentrations, this average was also used for the [DHAP] and [Gly-3-P] calculated by the model.
The ratio of cytosolic and glycosomal volume was 22.3. Rates are expressed in nmol min21 mg of protein21, and concentrations are in mM. When
experimental data are available for comparison, boldface numbers are used.
Independent transport of Gly-3-P and
DHAP Gly-3-P:DHAP antiporter Measured
ratio
Aerobic Anaerobic Ratio Aerobic Anaerobic Ratio
Glucose consumption rate 74 74 1.0 74 75 0.99 1
ATP/ADPc 3.0 1.5 2.0 3.0 1.5 2.0 2.4
ATP/ADPg 1.0 0.63 1.6 0.94 1.7 0.55
DHAPc 1.1 0.41 2.7 1.5 0.17 8.82
DHAPg 1.1 0.41 2.7 1.1 0.67 1.6
DHAPaverage 1.1 0.41 2.7 1.5 0.20 7.5 2.3
3-PGA 0.68 0.47 1.5 0.69 0.47 1.5 4.1
2-PGA 0.13 0.087 1.5 0.13 0.088 1.5 1.8
P-enolpyruvate 0.86 0.58 1.5 0.86 0.59 1.5 1.9
Gly-3-Pc 3.5 5.8 0.6 3.5 4.8 0.73
Gly-3-Pg 3.5 5.8 0.6 2.6 19.7 0.13
Gly-3-Paverage 3.5 5.8 0.6 3.5 5.7 0.61 0.25
TABLE II
The fluxes as measured under aerobic conditions at 37 °C
Note that the measured fluxes were higher than the calculated fluxes
(Table I), since the model refers to 25 °C (37).
Substrate
Flux (nmol min21 mg
of protein21) or flux
ratio
Glucose 2152
Pyruvate 339
Glycerol 7
O2 2158 6 11
JO2/Jglucose 1.0
Jpyruvate/Jglucose 22.2
Jglycerol/Jglucose 0.0
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enzymes.
In view of the uncertainty of the exact Vmax of the glucose
transporter and possible variation between trypanosome pop-
ulations or between individual cells within populations, it is
hard to predict where in the curve of Fig. 4 a trypanosome will
be. What can be predicted is which enzymes do control the flux
at increased transport activities. To this end, the transport
activity was increased by 35%, and the flux control distribution
was calculated again. Under aerobic conditions, ALD, GAPDH,
PGK, and GDH assumed most of the control, and again there
was no relationship between the flux control coefficients and
the displacement from equilibrium (Table IV). Under anaerobic
conditions, the Vmax of the glucose had to be doubled before the
transporter lost all control (Fig. 4). Then ALD, GAPDH, PGK,
GDH, and GK together took over control (result not shown).
Experimental Determination of the Sensitivity of the Glyco-
lytic Flux to Inhibition of Glucose Transport—Since modeling
alone was not sufficient to decide whether or not glucose trans-
port controlled the glycolytic flux, additional experiments were
carried out. Glucose transport was inhibited by increasing con-
centrations of phloretin, and the rate of oxygen consumption
was measured at 0.5 and 5 mM glucose (Fig. 5, circles). The rate
of oxygen consumption is a measure of the glycolytic flux, since
bloodstream form trypanosomes consume one molecule of oxy-
gen per molecule of glucose under aerobic conditions (Table II).
Phloretin is a competitive inhibitor of glucose transport into
erythrocytes (55). One report claims that it is a non-competitive
inhibitor of trypanosome glucose transport (56). However, this
conclusion was based on measurements of the glycolytic flux,
rather than of initial transport, and no data were given. There-
fore, the phloretin titrations were simulated, either assuming
non-competitive (Fig. 5, A and B, or competitive inhibition (Fig.
5, C and D). When non-competitive inhibition was assumed, it
was impossible to simulate the data at a low and at a high
glucose concentration with the same inhibition constant (Fig. 5,
A and B). With a competitive inhibitor, the model results ap-
proached the measurements, with a single inhibition constant
(Fig. 5, C and D). However, to obtain a satisfactory agreement
between model and measurements, it was necessary to increase
the Vmax of the glucose transporter above the measured value.
This may indicate that the real flux control coefficient of glu-
cose transport at 5 mM glucose is substantially lower than 1,
implying that other steps also exert control. The flux control
coefficient of the glucose transporter is higher than 0, since the
lowest concentration of phloretin already inhibited the flux. All
in all, these experiments confirmed the conclusion of the ki-
netic calculations that the glucose transporter carries signifi-
cant but not all control.
The Distribution of Control between the Supply and Demand
for ATP—A main function of glycolysis is to supply the cell with
the ATP necessary for all free energy-requiring processes. This
is especially true for bloodstream form trypanosomes in which
glycolysis is the only source of ATP. Therefore, it was surpris-
ing that the utilization of ATP had no control of the glycolytic
flux in the model (Tables III and IV). What caused this lack of
control by ATP utilization?
Zooming away from the details, we considered the glycolytic
pathway as consisting of two modules: one producing cytosolic
ATP (supply) and one consuming it (demand) (20, 50, 51). The
only common intermediate connecting these modules is the
cytosolic [ATP]/[ADP] ratio. The distribution of control between
the supply and demand modules should depend on their rela-
tive sensitivity to the common intermediate. The more sensi-
tively a module responds to a changing cytosolic [ATP]/[ADP]
ratio, the less control over the flux it should have (see “Mate-
rials and Methods” for mathematical details). Therefore, the
low control by the demand for ATP can be due to two reasons;
either the demand is extremely sensitive to changes of the
[ATP]/[ADP] ratio or the supply is hardly sensitive to this ratio.
These sensitivities were quantified in terms of elasticity coef-
ficients (Equation 20). When we compared the sensitivities of
the supply and the demand module, it turned out that the
control by ATP utilization was so low because the supply rate of
ATP was held totally insensitive to the [ATP]/[ADP] ratio. The
elasticity coefficient of the latter was lower than 1023 at [ATP]/
[ADP] ratios between 1 and 8. Thus, the supply module could
not respond to changes of ATP utilization. Due to the compart-
mentalization of glycolysis, the cytosolic [ATP]/[ADP] ratio is
only sensed by PYK. Not only was PYK itself only weakly
sensitive to the [ATP]/[ADP] ratio (its elasticity coefficient was
20.24 at 5 mM extracellular glucose), but it also had little
control on the flux through the supply module (less than 0.2%).
Even if PYK was made more sensitive to the [ATP]/[ADP] ratio
(an elasticity coefficient of 20.9) by including product inhibi-
tion by ATP (Equation 3), this was not transmitted to the rest
of the supply module due to the low control by this enzyme (still
less than 2%). One way to increase the control of the supply flux
by PYK and concomitantly to increase the flux control by the
demand reaction was to decrease the Vmax of PYK to below 156
nmol min21 mg of protein21 in the absence of product inhibi-
tion or below 780 nmol min21 mg of protein21 with product
inhibition. However, this is only 6 or 30%, respectively, of the
activity measured by two independent groups (7, 47). It seems
more likely that our calculation that there resides little control
in PYK and ATP utilization is realistic.
How Can Trypanosome Glycolysis Be Inhibited Effectively?—
One intended application of this study is the identification of
the best drug targets of trypanosome glycolysis. Table V re-
ports the extent to which each enzyme had to be inhibited for
the glycolytic flux to drop by 50%. The glucose transporter
appeared to be the most promising candidate target, since only
51% inhibition of the transporter sufficed to inhibit the flux by
50%. ALD, GDH, GAPDH, and PGK, enzymes that under some
conditions shared control, were intermediate candidates. Sur-
prisingly, HK, PFK, and PYK, enzymes that are often thought
to control glycolysis, were the poorest candidates from this
perspective. They had to be inhibited by 93% or more to reduce
the flux by 50%. To investigate whether these enzymes were
present in excess, it was also calculated which enzyme inhibi-
tion was required for a 10% inhibition of the flux (Table V).
Again, glucose transport was the most effective drug target,
followed by ALD, GAPDH, GDH, and PGK. Indeed HK, PFK,
and PYK appeared to have a huge overcapacity.
DISCUSSION
This study has addressed the question of which steps control
the glycolytic flux in bloodstream form T. brucei. The unique
situation that a sufficiently complete set of kinetic data is
available for a single condition made it possible to calculate an
FIG. 3. The flux control coefficient of the glucose transporter
depends on the extracellular glucose concentration. This result
was obtained under aerobic conditions. The inset shows the flux control
coefficients of those enzymes that take over control, when the trans-
porter loses control at 10 mM glucose.
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answer to this question. The model that was used in this study
was based on this data set and had been validated experimen-
tally (37). The pertinence of our calculations is limited mainly
by lack of kinetic information on the metabolite transporters
across the glycosomal membrane. If these steps do not operate
at equilibrium, as was assumed in this study, the current
model overestimates the other flux control coefficients. How-
ever, since the glycosome can be considered as a monofunc-
tional unit (49), the ratios of the flux control coefficients of the
glycosomal enzymes are not compromised by this uncertainty.
The results presented in this study are at variance with the
deceptive consensus in the literature that glucose transport is
the rate-limiting step of trypanosome glycolysis (17, 29, 43, 56),
for the control of glycolysis by the glucose transporter was less
than complete, and it depended considerably on both the ex-
tracellular glucose concentration and the enzyme activities. A
steep shift of control was calculated upon varying the activity of
the glucose transporter itself (Fig. 4). Further calculations re-
vealed that this sudden drop of control resulted from the large
difference between the Km values of the glucose transporter (2
mM) and HK (0.1 mM) for intracellular glucose in this model
(57). Also an increase of the “apparent” Km of HK for glucose by
a decrease of its Km for the product Glc-6-P weakened the
dependence of the control by the transporter on transporter
activity (result not shown). However, the Km of 12 mM for
Glc-6-P that was used here is the lowest Km that could be
reconciled with all kinetic studies reported so far. This suggests
that the strong shift of control may well occur in living trypano-
somes. Would it also occur in the host cells? In mammalian
cells, the difference between the Km values of glucose transport
and HK is similar to that in trypanosomes or even more ex-
treme (58–60). Indeed, a shift of control has been observed in
perfused rat heart upon stimulation of the transporter by in-
sulin (36). Insulin may, however, cause a large change of the
transport activity, and it is not known whether a small change
of the transport activity is sufficient to cause the decrease of
control, as it did in the trypanosome model. It may be expected
that the shift of control is less abrupt in mammalian cells than
in trypanosomes, since the affinity of mammalian hexokinase I,
II, and III toward Glc-6-P is very high (59).
Our calculations used a single kinetic equation for the utili-
zation of ATP, obscuring the variety of processes in which ATP
is consumed. Ideally, if one of these processes is activated due
to a change of the extracellular conditions, the others should
not slow down, but the supply of ATP, i.e. the glycolytic flux,
should adjust to the altered demand (20, 21). The cell can
achieve this either by making the supply very sensitive to the
cytosolic [ATP]/[ADP] ratio or by making the demand reactions
very insensitive to this ratio. The former strategy ensures at
the same time homeostasis of the cytosolic [ATP]/[ADP] ratio.
Hofmeyr and Cornish-Bowden (51) argued that “the regulatory
performance of the system can be judged in terms of how
sensitive the fluxes respond to the external stimulus and to
what degree homeostasis in the concentrations of the internal
regulators is maintained.” In the case discussed here, this
external stimulus could be anything changing the demand for
ATP, and the internal regulator is the cytosolic [ATP]/[ADP]
ratio. By this criterion, trypanosome glycolysis worked as a
TABLE III
The control of the glycolytic flux (Ci
J) and the displacement from equilibrium (G/Keq) under aerobic conditions
Flux control coefficients were calculated according to Equation 18. The displacement from equilibrium was quantified as the actual ratio of
product to substrate concentrations (G) divided by the equilibrium constant (Keq). The extracellular glucose concentration was varied between its
physiological boundaries. The most common blood glucose concentration is 5 mM. Control coefficients above 5% have been set in boldface.
Reaction
4 mM glucose 5 mM glucose 8 mM glucose
Ci
J G/Keq Ci
J G/Keq Ci
J G/Keq
% % %
Glucose transport 95 5.5 z 1023 90 6.1 z 1023 63 9.2 z 1023
HK 2 ,,1023 2 ,,1023 4 ,,1023
PFK 0 ,,1023 0 ,,1023 1 ,,1023
ALD 1 0.25 2 0.22 10 0.17
GAPDH 1 0.25 2 0.23 9 0.20
PGK 1 9.5 z 1023 2 7.2 z 1023 6 3.4 z 1023
PYK 0 ,,1023 0 ,,1023 1 ,,1023
Pyruvate transport 0 ,,1023 0 ,,1023 0 ,,1023
GDH 1 8.0 z 1023 2 8.4 z 1023 6 9.1 z 1023
Glycerol-3-phosphate oxidase 0 ,,1023 0 ,,1023 1 ,,1023
ATP utilization 0 0 0
FIG. 4. The flux control coefficient of the glucose transporter
sharply decreases with increasing transport activity. These re-
sults were obtained at 5 mM extracellular glucose. The solid lines
represent aerobic conditions, and the dashed lines anaerobic conditions.
The markers indicate the default forward Vmax (106.2 nmol min
21 (mg
of protein)21) at which all of the above results were obtained. The
forward and reverse Vmax were varied proportionally to avoid violation
of the equilibrium constant.
TABLE IV
The control of the glycolytic flux (Ci
J) and the displacement from
equilibrium (G/Keq) at increased glucose transport activity
Both the forward and the reverse Vmax were increased by 35% so that
the forward Vmax became 143.4 nmol min
21 mg of protein21. The extra-
cellular glucose concentration was 5 mM. All other parameters were the
same as for Table I. Control coefficients above 5% are given in boldface.
Reaction Ci
J G/Keq
%
Glucose transport 8 6.0 z 1022
HK 5 ,,1023
PFK 1 ,,1023
ALD 28 0.15
GAPDH 23 0.21
PGK 15 1.7 z 1023
PYK 1 ,,1023
Pyruvate transport 0 ,,1023
GDH 17 9.6 z 1023
Glycerol-3-phosphate oxidase 2 ,,1023
ATP utilization 0
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poor regulatory performer; the control by demand was very low
because the supply module hardly sensed the cytosolic [ATP]/
[ADP] ratio.
This result raises the question of whether homeostasis of the
[ATP]/[ADP] ratio is unimportant for bloodstream form
trypanosomes. Alternatively, if homeostasis is important, are
these cells unable to cope with changes of their environment
that affect the demand for ATP? Trypanosomes living in the
bloodstream enjoy a relatively constant environment. Probably
the most dramatic event these trypanosomes experience is the
transfer from the mammalian bloodstream to the midgut of the
tsetse fly. The “long slender” bloodstream form, which is dom-
inant in the blood, does not survive this sudden transfer. Only
the intermediate “short stumpy” bloodstream form is able to
adapt to the new environment (61). Our calculations predicted
that a 90% decrease of the activity of PYK was required to shift
the control to the demand for ATP. Perhaps fructose 2,6-
bisphosphate, a potent activator of PYK, plays an important
role in the transition from the long slender to the intermediate
form of T. brucei. In bloodstream form trypanosomes, PYK is
saturated with fructose 2,6-bisphosphate (12, 16). An interest-
ing test of this hypothesis is to measure whether the interme-
diate “short stumpy” form of T. brucei has a strongly reduced
concentration of fructose 2,6-bisphosphate and, consequently, a
higher control by the demand for ATP.
The present study has strong implications for the design of
anti-trypanosomal drugs; inhibition of the transport of glucose
into the cells should be much more effective than inhibition of
any of the other steps. Until now the design and synthesis of
inhibitors of trypanosome glycolysis has been focused on the
enzymes GAPDH (62–67), PGK (68), and ALD (63). According
to our model calculations, inhibition of these steps should be
less effective than inhibition of glucose transport but far more
effective than inhibition of HK, PFK, or PYK. Does this imply
that all effort should be shifted to the synthesis of inhibitors of
glucose transport? No, some certainly, but not all; the differ-
ence of effectiveness between inhibition of GAPDH and inhibi-
tion of the glucose transporter may be overcome by the design
of an inhibitor of GAPDH or PGK that is 2-fold more effective
at the level of the single protein. The real gain of our method
may not be an increase of effectiveness but rather an increase
of selectivity. If one optimizes the selectivity of the inhibitor at
the enzyme level, the inhibition of the host enzyme may be only
weak. If, on top of this, the enzyme of interest has a much lower
flux control in the host than in the parasite, the compound
should inhibit the flux manifold more selectively than it inhib-
its the single enzyme. From an elaborate model of erythrocyte
glycolysis, it was concluded that a 95% deficiency of ALD,
GAPDH, or PGK should not cause any clinical symptoms (69).
Since these enzymes exerted flux control in trypanosomes,
drugs directed against these enzymes have a high probability of
being selective against trypanosome glycolysis.
Acknowledgments—We thank S. Marche´ and J. van Roy for the
sharing of unpublished results and B. Teusink and K. van Dam for
careful reading of the manuscript and fruitful discussions.
FIG. 5. Inhibition of glucose transport by phloretin. The rate of oxygen consumption was measured (circles) and simulated (lines) at various
concentrations of the glucose transport inhibitor phloretin and both at 0.5 mM (A and C) and 5 mM glucose (B and D). Open and closed symbols
represent independent experiments with trypanosomes isolated from different rats. In A and B, it was assumed in the simulations that the
inhibition was non-competitive, with a Ki of 13 mM, and at the default Vmax of glucose transport (106.2 nmol min
21 mg of protein21). In C and D,
competitive inhibition with a Ki of 18 mM was simulated, and the Vmax of glucose transport was, respectively, 160 (highest line in D), 170, 180, and
190% (lowest line in D) of the default value of 106.2 nmol min21 mg of protein21. At 0.5 mM glucose (C), the inhibition curves at different Vmax values
overlapped.
TABLE V
The inhibition of each individual enzyme required to inhibit the flux
by 10 and 50%
These results were obtained at 5 mM glucose under aerobic conditions
and at constant values of all other enzyme activities. The forward and
reverse Vmax were varied simultaneously by the same percentage.
Reaction
Inhibition required
10% flux reduction 50% flux reduction
%
Glucose transport 11 51
HK 77 93
PFK 87 93
ALD 44 76
GAPDH 53 84
PGK 61 85
PYK 94 97
GDH 56 83
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